LFCR MEXC RealStocks
Own real LFCR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-22 10:39:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Lifecore Biomedical, Inc. (LFCR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.39, with a market capitalization of $242.22M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.63 to $8.98. This page covers its latest market performance, valuation, price trends and company information.
$242.22M | |
$6.37 | |
$6.39 | |
$6.37 | |
$6.37 | |
179.97K | |
419.82K | |
-- | |
$8.98 | |
$3.63 | |
-- | |
2026-09-30 |
Lifecore Biomedical, Inc. (LFCR) last closed at $6.39 as of 2026-11-21 00:31:00, up 0.24% ($0.01) from the previous close of $6.37.
During the latest regular trading session, LFCR traded between $6.37 and $6.39, with a volume of 179.97K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Lifecore Biomedical, Inc. (LFCR) moved from $6.40 to $6.39, representing a decline of 0.23% ($0.02).
The stock traded between $6.35 and $6.42 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 163.99 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 51.5%
LFCR is currently trading at $6.39, placing it 51.5% of the way from its 52-week low of $3.63 to its 52-week high of $8.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 382 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lifecore Biomedical, Inc. (LFCR) through MEXC Stocks. Follow these three steps to open a Stocks account, transfer USDT, and place a Stocks order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LFCR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LFCR shares and USD.
LFCR Shares to USD
1.00 LFCR shares = 6.385 USD
Calculations are estimates based on the latest available price and are for reference only.